Skip to main content

The expanded role of fatty acid metabolism in cancer: new aspects and targets.

Publication ,  Journal Article
Chen, M; Huang, J
Published in: Precis Clin Med
September 2019

Cancer cells undergo metabolic reprogramming to support cell proliferation, growth, and dissemination. Alterations in lipid metabolism, and specifically the uptake and synthesis of fatty acids (FAs), comprise one well-documented aspect of this reprogramming. Recent studies have revealed an expanded range of roles played by FA in promoting the aggressiveness of cancer while simultaneously identifying new potential targets for cancer therapy. This article provides a brief review of these advances in our understanding of FA metabolism in cancer, highlighting both recent discoveries and the inherent challenges caused by the metabolic plasticity of cancer cells in targeting lipid metabolism for cancer therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Precis Clin Med

DOI

EISSN

2516-1571

Publication Date

September 2019

Volume

2

Issue

3

Start / End Page

183 / 191

Location

England
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, M., & Huang, J. (2019). The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis Clin Med, 2(3), 183–191. https://doi.org/10.1093/pcmedi/pbz017
Chen, Ming, and Jiaoti Huang. “The expanded role of fatty acid metabolism in cancer: new aspects and targets.Precis Clin Med 2, no. 3 (September 2019): 183–91. https://doi.org/10.1093/pcmedi/pbz017.
Chen M, Huang J. The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis Clin Med. 2019 Sep;2(3):183–91.
Chen, Ming, and Jiaoti Huang. “The expanded role of fatty acid metabolism in cancer: new aspects and targets.Precis Clin Med, vol. 2, no. 3, Sept. 2019, pp. 183–91. Pubmed, doi:10.1093/pcmedi/pbz017.
Chen M, Huang J. The expanded role of fatty acid metabolism in cancer: new aspects and targets. Precis Clin Med. 2019 Sep;2(3):183–191.

Published In

Precis Clin Med

DOI

EISSN

2516-1571

Publication Date

September 2019

Volume

2

Issue

3

Start / End Page

183 / 191

Location

England